Jean Bourcereau
President chez Ventech SA
Provenance du réseau au premier degré de Jean Bourcereau
Entité | Type d'entité | Industrie | |
---|---|---|---|
Ventech SA
Ventech SA Investment ManagersFinance Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US.
17
| Subsidiary | Investment Managers | 17 |
Crocus Technology International Corp.
Crocus Technology International Corp. SemiconductorsElectronic Technology Crocus Technology SA develops magnetically enhanced semiconductor technologies. Its products include microcontrollers, magnetic logic units, access control, CTMP memory, and magnetic sensors. The firm’s services encompass licensing and design. It caters to mobile phone manufacturers. The company was founded by Jean-Pierre Nozieres, Jean-Pierre Braun, Thierry Chavigner and Jacques Noels in 2004 and is headquartered in Grenoble, France.
15
| Subsidiary | Semiconductors | 15 |
InterCloud SAS
InterCloud SAS Information Technology ServicesTechnology Services interCloud SAS is a holding company, which develops software solutions. It offers service oriented platform for cloud applications and managed solutions. The company was founded by Jérôme Dilovya, Antoine Valat, and Benjamin Ryzman in 2010 and is headquartered in Paris, France.
6
| Holding Company | Information Technology Services | 6 |
Pinklab360 SASU
Pinklab360 SASU Internet Software/ServicesTechnology Services Pinklab360 SASU, trading as misterb&b, operates as an apartment and accommodation booking platform. It caters to customers from the lesbian, gay, bisexual, transgender, and questioning (LGBTQ) community. The company was founded on October 14, 2015 and is headquartered in Paris, France.
6
| Holding Company | Internet Software/Services | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jean Bourcereau via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
AMD (ADVANCED MICRO DEVICES) | Semiconductors | Corporate Officer/Principal Corporate Officer/Principal | |
INTEL CORPORATION | Semiconductors | Corporate Officer/Principal Corporate Officer/Principal | |
QUALCOMM, INC. | Semiconductors | Chief Operating Officer | |
TEXAS INSTRUMENTS INCORPORATED | Semiconductors | Corporate Officer/Principal Sales & Marketing | |
Silicon Storage Technology, Inc.
Silicon Storage Technology, Inc. SemiconductorsElectronic Technology Silicon Storage Technology, Inc. designs, manufactures and markets nonvolatile memory solutions. It supplies flash memory semiconductor devices for the digital consumer, networking, wireless communications and the Internet computing markets. The firm produces and sells semiconductor products, including flash controllers and controller-based modules, smart card integrated circuits and modules, flash microcontrollers and radio frequency devices and modules. The company was founded in 1989 and is headquartered in San Jose, CA. | Semiconductors | Corporate Officer/Principal Corporate Officer/Principal | |
TSA SAS | Telecommunications Equipment | Corporate Officer/Principal Director/Board Member | |
ALTRAN TECHNOLOGIES | Miscellaneous Commercial Services | Corporate Officer/Principal | |
OneAccess SA
OneAccess SA Computer CommunicationsElectronic Technology OneAccess SA designs, manufactures and markets broadband access equipment for telecommunications carriers and corporate networks. The firm’s products include multi-service access routers and carrier Ethernet devices and WAN optimization appliances. The company was founded in 2001 and is headquartered in Clamart, France. | Computer Communications | Director/Board Member Director/Board Member | |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member | |
TIGENIX NV | Medical Specialties | Director/Board Member | |
KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
LBO France Gestion SAS
LBO France Gestion SAS Investment ManagersFinance LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France. | Investment Managers | Private Equity Investor Private Equity Investor | |
École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree | |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
Teem Photonics SA
Teem Photonics SA SemiconductorsElectronic Technology Teem Photonics SA manufactures optical network components. The firm specializes in Q-switched micro lasers as well as photonics integrated circuits based on ion exchange technology. Its products are used in a variety of industrial and biophotonics applications includes fluorescence, spectroscopy, gem marking, microdissection, communications, ranging, and as seeds for fiber lasers and supercontinuum generation. The company was founded by Antoine Kévorkian and Denis Barbier in 1998 and is headquartered in Meylan, France. | Semiconductors | Director/Board Member Director/Board Member | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
Technion-Israel Institute of Technology | College/University | Undergraduate Degree | |
Gimv (Private Equity)
Gimv (Private Equity) Investment ManagersFinance Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium. | Investment Managers | Director/Board Member | |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member | |
École Centrale Paris | College/University | Undergraduate Degree | |
Ecole Polytechnique | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
Omnes Capital SAS /Venture/
Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris. | Investment Managers | Director of Investments Private Equity Analyst | |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member | |
Université Paris II Panthéon Assas | College/University | Graduate Degree | |
Covagen AG
Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
ISAI Gestion SAS
ISAI Gestion SAS Investment ManagersFinance ISAI Gestion SAS (ISAI) is a network of business angels established in 2008 and headquartered in Paris. The fund was founded by Pierre Morizet-Kosciusko, Ouriel Ohayon, Geoffroy Roux de Bezieux, Stephane Treppoz. ISAI's active investors are entrepreneurs. Individuals connected with the active investors also provide capital without getting involved in operations. The firm manages a tax-advantaged investment vehicle designed for high-net worth individuals. ISAI's name derives from a Japanese Kanji conveying uniqueness, and also stands for International Society of Angel Investors. | Investment Managers | Private Equity Investor | |
FittingBox SA
FittingBox SA Packaged SoftwareTechnology Services FittingBox SA provides interactive solutions and digital contents to the eyewear industries. It builds and maintains the largest database of 3D views of frames for virtual try-on solutions. The firm also provides web modules that allow visitors to website to try on, in just a few clicks, entire eyewear collection will be presented on photos. The company was founded by Ariel Choukroun and Benjamin Hakoun in August 2006 and is headquartered in Toulouse, France. | Packaged Software | Director/Board Member Director/Board Member | |
Institut d'Administration des Entreprises de Paris | College/University | Masters Business Admin | |
DST Holding SAS
DST Holding SAS Engineering & ConstructionIndustrial Services Part of SSCV Investments SARL, DST Holding SAS operates as a holding French company. | Engineering & Construction | Chairman Director/Board Member | |
Mydeal SARL
Mydeal SARL Catalog/Specialty DistributionRetail Trade Mydeal SARL operates a website which offers daily deals and discounts. It provides deals on categories such as beauty, wellness, restaurants, entertainment and shopping. The firm sends emails to the customers to receive offers through subscriptions. The company was founded by Mounia Rkha and Fayçal Fassi-Fihri in September 2010 and is headquartered in Casablanca, Morocco. | Catalog/Specialty Distribution | Chief Executive Officer | |
Girls In Tech Paris
Girls In Tech Paris Miscellaneous Commercial ServicesCommercial Services Girls In Tech Paris is a private company that aims to address the gender gap in the tech industry. The company was founded by Mounia Rkha and is based in Paris, France. The French company's mission is to empower and support women in the tech industry, as research has shown that female programmers are often discriminated against. The company seeks to create a community where women can thrive and succeed in the tech industry. | Miscellaneous Commercial Services | Founder | |
Gimv Germany | Investment Managers | Private Equity Investor | |
Aleph Capital Partners LLP
Aleph Capital Partners LLP Investment ManagersFinance Aleph Capital Partners LLP (Aleph Capital Partners) is an independent private equity firm founded in 2013 by Hughes B. Lepic. The firm is headquartered in London, United Kingdom. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Confo Therapeutics NV
Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member | |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
France | 24 |
Etats-Unis | 13 |
Belgique | 6 |
Royaume-Uni | 4 |
Suisse | 3 |
Sectorielle
Health Technology | 14 |
Electronic Technology | 12 |
Finance | 11 |
Consumer Services | 9 |
Commercial Services | 5 |
Opérationnelle
Director/Board Member | 145 |
Corporate Officer/Principal | 45 |
Private Equity Investor | 26 |
Chief Executive Officer | 23 |
Founder | 19 |
Relations les plus connectées
Insiders | |
---|---|
Valéry Huot | 41 |
Mounia Chaoui-Roulleau | 27 |
Michel Desbard | 27 |
Sanjay Jha | 26 |
Hughes Bernard Lepic | 26 |
Alain Caffi | 17 |
Karl Nägler | 16 |
Christian Claussen | 14 |
Aymeric Sallin | 14 |
Jacques Noëls | 10 |
Alain Maïore | 7 |
Douglas Lee | 7 |
Alain Faburel | 7 |
Wayne Godwin | 7 |
Jocelyne Cérasa | 7 |
- Bourse
- Insiders
- Jean Bourcereau
- Connexions Sociétés